These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients. Chouinard G; Jones B; Remington G; Bloom D; Addington D; MacEwan GW; Labelle A; Beauclair L; Arnott W J Clin Psychopharmacol; 1993 Feb; 13(1):25-40. PubMed ID: 7683702 [TBL] [Abstract][Full Text] [Related]
10. High incidence of tardive dyskinesia in older outpatients on low doses of neuroleptics. Harris MJ; Panton D; Caligiuri MP; Krull AJ; Tran-Johnson TK; Jeste DV Psychopharmacol Bull; 1992; 28(1):87-92. PubMed ID: 1609047 [TBL] [Abstract][Full Text] [Related]
11. Tardive dyskinesia in a patient taking haloperidol and fluoxetine. Stein MH Am J Psychiatry; 1991 May; 148(5):683. PubMed ID: 2018175 [No Abstract] [Full Text] [Related]
12. Serum concentrations of haloperidol pyridinium metabolites and the relationship with tardive dyskinesia and parkinsonism: a cross-section study in psychiatric patients. Ulrich S; Sandmann U; Genz A Pharmacopsychiatry; 2005 Jul; 38(4):171-7. PubMed ID: 16025420 [TBL] [Abstract][Full Text] [Related]